The editor is here to introduce popular science, transcatheter mitral valve intervention (TMV) is an emerging technology that uses transcatheter intervention to treat the mitral valve that needs treatment. At present, the TMV global market is booming and is in a stage of rapid growth.
From the perspective of the global market structure, Abbott has MitraClip and Tendyne in hand, leading the overall market. In China, 2021 is the first year for the commercialization of transcatheter mitral valve intervention. The relevant market size is predicted to be 52.5 million yuan that year. Domestic competition is fierce, and more than 20 companies have entered the market.
At present, the industry has the following pain points: agglomeration of foreign leaders, obvious market monopoly, frequent industry lawsuits, and high patent risks.
In response to the above pain points, Wisdom Buds will launch the first course of the medical device industry high-quality course at 19:30 on April 21 (Thursday) - "Panoramic Insights on Transcatheter Mitral Valve Therapy Technology" , starting from the technical overview and industry status quo. , through the industry's patent information to gain insight into relevant market intelligence, and share with you the panoramic insights of transcatheter mitral valve treatment technology.
Course Details
Lecturer Profile
Zhang Lin Zhiya Senior Intellectual Property Consultant
Master, graduated from Southeast University majoring in biomedical engineering, patent attorney, intermediate title of intellectual property. More than 5 years of overseas patent agency + intellectual property consulting experience.
He has undertaken various patent consulting projects for a long time, and served clients including Medtronic, United Imaging Medical, Kemei Diagnostics, Lanfan Boyuan, etc. He is good at patent retrieval and intelligence analysis, risk management and control, patent layout, etc.
Hurry up to scan the code to register
Focus on innovation hotspots in the medical device industry
Get the latest industry insights
Join the medical device industry community
Interact with peers
Wisdom Bud
PatSnap was established in 2007. As a technology-based global R&D innovation information and management provider, PatSnap has always been committed to creating better information and intelligence for innovators with years of accumulated artificial intelligence technology and big data processing capabilities. Platform and Services.
By providing a rich and user-friendly product portfolio and solutions, Wisdom Buds helps customers easily obtain technological competitive intelligence from intellectual property and other information, and promotes the commercialization process to improve the core competitiveness of customers' innovation. Since its establishment, Wisdom Buds has served more than 10,000 customers in more than 50 countries around the world.
Recommended by companies
Apple Dynamic Network Services Oracle America Sensormatic Electronics IBM Ikeda Bussan BYD Huawei Technologies ZTE Mitsubishi Electric Engineering Google Samsung Electronics QUALCOMMFreddie MacFederal National MtgeSiemensUnitedHealth GroupGeneral Electric Co Oracle AESMarriott InternationalShellWelltowerHCA HealthcareWestconnexMeituanThermo Fisher ScientificTesla SeaCruiseAir CanadaLineage LogisticsLucid Motors PatSnap
If you like it, please like it and watch it!